Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Getinge ( ($SE:GETI.B) ) is now available.
Getinge will publish its first‑quarter 2026 results on April 21 and will host a same‑day conference call led by President and CEO Mattias Perjos and CFO Agneta Palmér. Fund managers, analysts and media can join via teleconference or webcast, with a recorded version of the presentation available for three years, underscoring the company’s focus on transparency and active engagement with capital markets.
The Q1 reporting and call provide stakeholders with an opportunity to assess Getinge’s operational performance early in the year and to gauge management’s strategic priorities in key segments such as intensive care and surgical workflows. The extended availability of the webcast also broadens access for global investors and analysts, reinforcing the company’s visibility in the medical technology sector and supporting informed investment decisions.
The most recent analyst rating on ($SE:GETI.B) stock is a Hold with a SEK201.00 price target. To see the full list of analyst forecasts on Getinge stock, see the SE:GETI.B Stock Forecast page.
More about Getinge
Getinge is a global medical technology company that supplies hospitals and life science institutions with products and solutions designed to improve clinical outcomes and streamline workflows. Its portfolio spans intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science applications, supported by roughly 12,000 employees and sales in 135 countries.
Average Trading Volume: 712,535
Technical Sentiment Signal: Sell
Current Market Cap: SEK52.08B
Find detailed analytics on GETI.B stock on TipRanks’ Stock Analysis page.